Cathelicidin-WA ameliorates diabetic cardiomyopathy by inhibiting the NLRP3 inflammasome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cathelicidin-WA ameliorates diabetic cardiomyopathy by inhibiting the NLRP3 inflammasome

Published:2021-09-29 Issue:21 Volume:20 Page:2278-2290
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Peng Meng¹,Liu Yuan¹,Xu Yawei¹,Li Li¹,Li Yan¹,Yang Haibo¹

Affiliation:

1. Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Funder

National Natural Science Foundation of China

Tianjin Science and Technology Committee

Science and Technology fund of Tianjin Binhai New Area Health and Family Planning Commission

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2021.1981631

Reference28 articles.

1. Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy

2. New type of cardiomyopathy associated with diabetic glomerulosclerosis

3. Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy

4. Diabetic cardiomyopathy, causes and effects

5. NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of NF-κB in diabetic cardiomyopathy;All Life;2024-09-05

2. Role of Cathelicidins in Atherosclerosis and Associated Cardiovascular Diseases;Journal of Molecular Pathology;2024-08-20

3. The study of the mechanism of non-coding RNA regulation of programmed cell death in diabetic cardiomyopathy;Molecular and Cellular Biochemistry;2024-01-08

4. A snake cathelicidin enhances transcription factor EB‐mediated autophagy and alleviates ROS‐induced pyroptosis after ischaemia–reperfusion injury of island skin flaps;British Journal of Pharmacology;2023-11-27

5. ОЦЕНКА СЫВОРОТОЧНЫХ УРОВНЕЙ L-FABP И КАТЕЛИКИДИНА КАК ДИАГНОСТИЧЕСКИХ МАРКЕРОВ ПРИ РАЗЛИЧНОЙ ПАТОЛОГИИ ПОЧЕК, ОБОСТРЯЮЩИХСЯ НА ФОНЕ ДИАБЕТА;Azerbaijan Medical Journal;2023-09-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3